<DOC>
	<DOCNO>NCT01889251</DOCNO>
	<brief_summary>The purpose study evaluate superiority regard vitreomacular adhesion ( VMA ) resolution single intravitreal injection A01016 ( Ocriplasmin ) compare sham-injection subject symptomatic VMA .</brief_summary>
	<brief_title>A Phase III Study A01016 Subjects With Symptomatic Vitreomacular Adhesion</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Symptomatic vitreomacular adhesion ( VMA ) , opinion Investigator , relate decreased visual function ; Best correct visual acuity ( BCVA ) 20/25 bad study eye ; BCVA 20/800 good nonstudy eye ; Provide write informed consent ; Follow specify instruction study period ; Other protocoldefined inclusion criterion may apply . Evidence proliferative retinopathy , exudative agerelated macular degeneration , retinal vein occlusion study eye ; Vitreous hemorrhage opacification ; High myopia study eye ; Ocular surgery , laser photocoagulation treatment , intravitreal injection ( ) study eye prior 3 month ; Uncontrolled glaucoma study eye ; History retinal detachment either eye ; Active infection either eye ; Pregnant childbearing potential utilizing acceptable form contraception ; Participation another investigational drug study within 30 day prior study ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vitreomacular Adhesion</keyword>
	<keyword>Vitreomacular Traction</keyword>
	<keyword>Vitreomacular Traction Syndrome</keyword>
	<keyword>Vitrectomy</keyword>
	<keyword>Central Visual Field Defect</keyword>
	<keyword>Blind Spot</keyword>
	<keyword>Intravitreal Injection</keyword>
	<keyword>Macula</keyword>
	<keyword>Retina</keyword>
	<keyword>Decreased Visual Acuity</keyword>
	<keyword>Visual Complaint</keyword>
	<keyword>SD-OCT</keyword>
	<keyword>Macular Hole</keyword>
</DOC>